Switch to:
NovaBay Pharmaceuticals Inc (AMEX:NBY)
EV/EBIT
-2.22 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, NovaBay Pharmaceuticals Inc's enterprise value is $32.69 Mil. NovaBay Pharmaceuticals Inc's operating income for the trailing twelve months (TTM) ended in Mar. 2014 was $-16.08 Mil. Therefore, NovaBay Pharmaceuticals Inc's EV/EBIT ratio for today is -2.22.

NBY' s 10-Year EV/EBIT Range
Min: 14.9   Max: 81.4
Current: -2.22

14.9
81.4

During the past 11 years, the highest EV/EBIT Ratio of NovaBay Pharmaceuticals Inc was 81.40. The lowest was 14.90. And the median was 26.50.

NBY's EV/EBITis ranked lower than
59% of the 806 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 32.81 vs. NBY: -2.22 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). NovaBay Pharmaceuticals Inc's enterprise value for the quarter that ended in Mar. 2014 was $44.15 Mil. NovaBay Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was $-16.08 Mil. NovaBay Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2014 was 0.00%.


Definition

NovaBay Pharmaceuticals Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=32.689/-16.076
=

NovaBay Pharmaceuticals Inc's current Enterprise Value is $32.69 Mil.
NovaBay Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was -4.15 (Jun. 2013 ) + -2.982 (Sep. 2013 ) + -4.866 (Dec. 2013 ) + -4.078 (Mar. 2014 ) = $-16.08 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

NovaBay Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Mar. 2014 )=Operating Income (TTM)/Enterprise Value (Q: Mar. 2014 )
=-16.076/44.145
= %

NovaBay Pharmaceuticals Inc's Enterprise Value for the quarter that ended in Mar. 2014 was $44.15 Mil.
NovaBay Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was -4.15 (Jun. 2013 ) + -2.982 (Sep. 2013 ) + -4.866 (Dec. 2013 ) + -4.078 (Mar. 2014 ) = $-16.08 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

NovaBay Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit 0.000.000.000.000.0013.540.000.000.000.00

NovaBay Pharmaceuticals Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
ev2ebit 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide